brivaracetam vs zonisamide
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of brivaracetam and zonisamide. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Briviact
Zonegran
Brivaracetam is a medicine used to treat partial-onset seizures. It helps to reduce the number of seizures you have.
Zonisamide is a medicine used with other medicines to treat partial seizures in adults with epilepsy. It belongs to a class of drugs called anticonvulsants.
Brivaracetam is used to treat partial-onset seizures. These seizures start in one part of the brain. It can be used alone or with other seizure medicines for people 1 month and older.
Zonisamide is used to treat partial seizures in adults who have epilepsy. Epilepsy is a brain disorder that causes repeated seizures. This medicine is used along with other seizure medicines to help control your seizures.
Brivaracetam binds to a protein in the brain called SV2A. This helps to reduce the electrical activity in the brain that causes seizures. It helps to stabilize nerve cells.
Zonisamide works by slowing down the electrical signals in the brain that cause seizures. It is thought to stabilize nerve cell membranes, which reduces the chance of seizures. It may also affect certain chemicals in the brain.
- • Feeling sleepy or tired
- • Dizziness
- • Fatigue
- • Nausea or vomiting
- • Feeling sleepy
- • Loss of appetite
- • Dizziness
- • Problems with coordination
- • Feeling agitated or irritable
- Seizure 1,810
- Therapy Interrupted 280
- Overdose 233
- Fatigue 230
- Somnolence 216
- Seizure 1,574
- Fatigue 697
- Somnolence 645
- Convulsion 623
- Dizziness 558
Brivaracetam can cause suicidal thoughts or actions. Watch for new or worsening depression, suicidal thoughts or behavior, or unusual changes in mood. Tell your doctor right away if you have any of these symptoms. Do not stop taking brivaracetam suddenly, as this may increase your risk of seizures.
If you are allergic to sulfonamide medicines, you should not take zonisamide. Using zonisamide with other medicines that also inhibit carbonic anhydrase (like topiramate) can increase the risk of metabolic acidosis, kidney stones, and high ammonia levels in the blood.
Tell your doctor if you are pregnant or plan to become pregnant. There is a pregnancy registry for women who take brivaracetam during pregnancy. Contact the North American Antiepileptic Drug (NAAED) Pregnancy Registry at 1-888-233-2334.
Tell your doctor if you are pregnant or plan to become pregnant. It is not known if zonisamide will harm your unborn baby. Talk to your doctor about the risks and benefits of taking zonisamide during pregnancy. It is also not known if zonisamide passes into breast milk, so talk to your doctor before breastfeeding.
How to Read This brivaracetam vs zonisamide Comparison
brivaracetam is classified in the Anticonvulsant (SV2A Ligand) drug class, while zonisamide sits within the Anticonvulsant (Sulfonamide) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, brivaracetam has 2,769 submissions while zonisamide has 4,097. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for brivaracetam or zonisamide.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.